Login to view video
Video

An NNI Symposium: HMOs: A window of opportunity or a strong weapon in strengthening immunity

Allergy
Gut Microbiota
Growth & Development

Human milk oligosaccharides (HMOs)  are a group of complex carbohydrates that are highly abundant in human milk and contribute to shaping the infant’s gut microbiome and immune system for immediate and long-term health benefits. HMOs are the 3rd largest solid component of human milk and over 200 HMOs have been identified so far. 2’FL and LNnT are among the most studied HMOs with clinical evidence to support immunity and the developing microbiome, but latest research on additional HMOs show promise in expanded benefits on gut, immune, brain and bone health.

Author(s): Lars Bode, Ryan Carvalho, Yvan Vandenplas, Carine Blanchard, Sagar K. Thakkar

Professor Lars Bode 
Lars Bode
Prof. Ryan Carvalho
Ryan Carvalho
Prof. Yvan Vandenplas
Yvan Vandenplas
person-default
Carine Blanchard
person-default
Sagar K. Thakkar

Presented at

6th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition (WCPGHAN) 2020

If you liked this post you may also like

Please log in to your profile so we can show recommended content.